Lataa...
Stem cells: a path towards improved epilepsy therapies
Despite the immense growth of new anti-seizure drugs (ASDs), approximately one-third of epilepsy patients remain resistant to current treatment options. Advancements in whole genome sequencing technology continues to identify an increasing number of epilepsy-associated genes at a rate that is outpac...
Tallennettuna:
| Julkaisussa: | Neuropharmacology |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075729/ https://ncbi.nlm.nih.gov/pubmed/31539537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2019.107781 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|